Socio-economic characteristics and quality of life in diabetes mellitus-relation to metabolic control

Abstract

Diabetes mellitus is a chronic metabolic disease with wide implications for well-being and social life. The aim of this cross-sectional, observational study was to describe possible differences in clinical characteristics, socio-economic factors and quality of life between diabetes patients in poor and good/acceptable metabolic control, as defined by levels of glycated haemoglobin A_1c. From a population-based register of diabetes patients at a clinical chemistry department, we selected 96 subjects in poor metabolic control (HbA_1c > 10%), and 96 subjects in good/acceptable (HbA_1c 6.5 - 7.5%) metabolic control, matched for sex, age and duration of diabetes. Each participant was sent a self-administered questionnaire regarding medical history, family situation and socio-economic background, as well as self-rated health based on a validated instrument (SF-36). The diabetes patients in poor metabolic control reported more retinopathy, vascular complications and nervous problems than did the patients in acceptable metabolic control. Furthermore, the group in poor metabolic control was also characterized by a lower educational level, a higher number of sick leave days or disability pension and a lower degree of physical activity. Both of the diabetic groups reported lower scorings for physical functioning, general health, vitality and mental health, than did a comparable non-diabetic group from another study. In summary, diabetic patients in poor metabolic control have a lower educational level and report more complications, nervous problems, sick leave days and disability pensions than patients in good/acceptable metabolic control. The lower degree of physical activity adds to the problems of the first group and should be the target for intervention to achieve better metabolic control.

Keywords

complications diabetes education quality of life social class.

Get full access to this article

View all access options for this article.

References

Henriksson F. , Jönsson B. Diabetes-the cost of illness in Sweden. Stockholm: Handelshögskolan and IHE (Institutet för Hälsoekonomi). IHE Working paper 1997: 4.

DCCT Research Group. Diabetes Control and Complications Trial (DCCT). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.

Ohkubo Y. , Kishikawa H. , Araki E. , et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulindependent diabetes mellitus: a randomized prospective 6-year study. Diab Res Clin Pract 1995; 28: 103-17.

Reichard P. , Berglund B. , Britz A. , et al. Intensified conventional insulin treatment retards the microvascular complications of insulin dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after five years. Dissertation. Stockholm, 1987.

The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on Quality-of-Life outcomes in the Diabetes Control and Complications Trial . Diabetes Care 1996; 19: 195-203.

Goldstein DE , Little RR , Wiedmeyer HM , et al. Is glycohemoglobin testing useful in diabetes mellitus? Lessons from the Diabetes Control and Complications Trial. Clin Chem Forum 1994; 40: 1637-40.

Klein R. , Klein BE , Jensen SC , et al. The relation of socioeconomic factors to the incidence of proliferative diabetic retinopathy and loss of vision. Ophthalmology 1994; 101: 68-76.

Connolly VM , Kesson CM Socioeconomic status and clustering of cardiovascular disease risk factors in diabetic patients. Diabetes Care 1996; 19: 419-22.

Nilsson P. , Johansson S-E. , Sundqvist J. Diabetes mortality and social class in Sweden-influence of age and gender . Diabetic Med 1998; 15: 213-9.

10.

Chaturvedi N. , Stephenson JM , Fuller JH The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM complication study . Diabetes Care 1996 ; 19: 423-30.

11.

Jeppsson JO , Jerntorp P. , Sundkvist G. , Englund H. , Nylund V. Measurement of Hba1c by a new liquid chromatographic assay methodology . Clin Chem 1986; 32: 1867-72.

12.

Sullivan M. , Karlsson J. , Ware JE The Swedish SF-36 health survey I. Evaluation of data quality, scaling assumptions, reliability, and construct validity across general populations in Sweden. Soc Sci Med 1995; 41: 1349-58.

13.

Netterström B. , Danborg L. , Olesen H. Glycated hemoglobin as a measure of physiological stress. Behav Med 1988; 14: 13-6.

14.

Hjelm K. , Isacsson Å. , Apelqvist J. , Sundqvist J. , Nyberg P. Foreign- and Swedish-born diabetic patients-a population-based study of prevalence, glycaemic control and social position. Scand J Soc Med 1996; 24: 24352.

15.

Wändell PE , Brorsson B. , Åberg H. Psychic and socioeconomic consequenses with diabetes compared to other chronic conditions. Scand J Soc Med 1997; 25: 39-43.

16.

Holme I. , Helgeland A. , Hjermann I. , Leren P. , LundJohansen PG Physical activity at work and at leisure in relation to coronary risk factors and social class: a 4-year mortality follow-up. The Oslo Study. Acta Med Scand 1981; 209: 277-83.

17.

Ford ES , Merritt RK , Heath GW , Powell KE , Washburn RA , Kriska A. , et al. Physical activity behaviors in lower and higher socioeconomic status populations. Am J Epidemiol 1991; 133: 1246-56.

18.

Blaum CS , Velez L. , Hiss RG , Halter JB Characteristics related to poor glycaemic control in NIDDM patients in community care. Diabetes Care 1997; 20: 7 - 11.